Respiratory Syncytial Virus Bronchiolitis: Rapid Evidence Review

Area of Science:

• Pediatrics
• Infectious Diseases
• Respiratory Medicine

Background:

• Bronchiolitis is the most frequent lower respiratory tract infection in infants and young children.
• Respiratory Syncytial Virus (RSV) is the leading viral pathogen responsible for bronchiolitis.
• RSV transmission occurs via respiratory droplets, with seasonal variations in incidence.

Purpose of the Study:

• To outline the clinical presentation, diagnosis, and management of Bronchiolitis.
• To highlight the role of Respiratory Syncytial Virus (RSV) as the primary etiological agent.
• To discuss supportive care strategies and recommended interventions.

Main Methods:

• Clinical diagnosis is the cornerstone for identifying bronchiolitis.
• Standard infection control precautions are advised for most patients.
• Prophylaxis with palivizumab is considered for high-risk infants.

Main Results:

• Initial symptoms include rhinorrhea, congestion, sneezing, and fever, progressing to cough, tachypnea, and respiratory distress.
• Routine radiography and viral testing are generally not recommended for diagnosis.
• Supportive care, including maintaining oxygen saturation above 90% and adequate hydration/nutrition, is the primary treatment approach.

Conclusions:

• Bronchiolitis management is primarily supportive, focusing on respiratory and nutritional support.
• Specific therapies like bronchodilators, corticosteroids, and antibiotics are not recommended.
• While typically self-limited, RSV bronchiolitis may be associated with an increased risk of developing asthma later in life.